2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis.

Journal article

K. Jarr, Y. Kojima, I. Weissman, N. Leeper
Arteriosclerosis, Thrombosis and Vascular Biology, 2022

Semantic Scholar DOI PubMed

Cite

APA Click to copy
Jarr, K., Kojima, Y., Weissman, I., & Leeper, N. (2022). 2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis. Arteriosclerosis, Thrombosis and Vascular Biology.

Chicago/Turabian Click to copy
Jarr, K., Y. Kojima, I. Weissman, and N. Leeper. “2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis.” Arteriosclerosis, Thrombosis and Vascular Biology (2022).

MLA Click to copy
Jarr, K., et al. “2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis.” Arteriosclerosis, Thrombosis and Vascular Biology, 2022.

BibTeX Click to copy

@article{k2022a,
  title = {2021 Jeffrey M. Hoeg Award Lecture: Defining the Role of Efferocytosis in Cardiovascular Disease: A Focus on the CD47 (Cluster of Differentiation 47) Axis.},
  year = {2022},
  journal = {Arteriosclerosis, Thrombosis and Vascular Biology},
  author = {Jarr, K. and Kojima, Y. and Weissman, I. and Leeper, N.}
}

Abstract

A key feature of atherogenesis is the accumulation of diseased and dying cells within the lesional necrotic core. While the burden of intraplaque apoptotic cells may be driven in part by an increase in programmed cell death, mounting evidence suggests that their presence may primarily be dictated by a defect in programmed cell removal, or efferocytosis. In this brief review, we will summarize the evidence suggesting that inflammation-dependent changes within the plaque render target cells inedible and reduce the appetite of lesional phagocytes. We will present the genetic causation studies, which indicate these phenomena promote lesion expansion and plaque vulnerability, and the interventional data which suggest that these processes can be reversed. Particular emphasis is provided related to the antiphagocytic CD47 (cluster of differentiation 47) do not eat me axis, which has emerged as a novel antiatherosclerotic translational target that is predicted to provide benefit independent of traditional cardiovascular risk factors.